Phosphorylation by Aurora kinase A and ubiquitination by MDM2 contribute to SETD2 proteasome‐mediated degradation in blast crisis CML patients. The gene discussed is MDM2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.